Target intelligence / Profile preview

Hydroxyapatite in dental enamel (HAP or HA)

Target
HAP or HA
Molecular classification
Other (Inorganic mineral), Calcium phosphate biomaterial
01

Overview

Hydroxyapatite is the main inorganic mineral component of dental enamel, making up approximately 95% by weight of enamel as highly organized, carbonated hydroxyapatite crystals formed from calcium and phosphate ions[2][4][5]. These crystals provide enamel with exceptional hardness and durability, forming a dense lattice that protects underlying tooth structures from mechanical forces and acid attack[2][3][4]. Enamel hydroxyapatite is arranged in long, thin structures known as enamel rods, surrounded by interrod enamel with different crystal orientation[2]. Demineralization (loss of calcium and phosphate from hydroxyapatite) is a key process in dental caries, while remineralization restores the crystal structure, a process promoted by calcium, phosphate, and fluoride ions[5][6]. Hydroxyapatite is not a protein receptor, enzyme, or typical drug target, but a naturally occurring bioceramic and critical substrate in dental health interventions. Drugs and biomimetic agents interact physically or chemically with hydroxyapatite to promote enamel repair, not through classic molecular targeting[1][2][5][6].

Other names
HydroxylapatiteHapHABiological hydroxyapatiteCarbonated hydroxyapatite
02

Mechanism of action

Remineralizing agents promote deposition of calcium and phosphate ions to repair and rebuild hydroxyapatite crystal structure. Fluoride ions can substitute for the hydroxyl group in the crystal to form fluorapatite, which is more acid resistant[5][6]

03

Biological functions

Structural support (main component of enamel)Protection against mechanical and chemical damageParticipation in remineralization/demineralization cycles
04

Disease associations

Dental caries (demineralization)Enamel erosionDental hypersensitivityNot a classic “disease target” but a substrate/material altered in pathologies
05

Safety considerations

Hydroxyapatite itself is biocompatible and well-toleratedNo known systemic toxicityUse as a biomaterial (e.g., in dental fillings) may depend on particulate size and formulation[1]
06

Interacting drugs

Remineralization agents (e.g., fluoride compounds)

2 more in the full profile.

07

Biomarkers

Degree of hydroxyapatite demineralization (indicator for caries risk)Surface microhardness of enamel

Beyond the preview

Go deeper on Hydroxyapatite in dental enamel (HAP or HA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydroxyapatite in dental enamel (HAP or HA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call